Zimeldine treatment of obsessive‐compulsive disorder: Biological and neuropsychological aspects

R. S. Kahn; H. G.M. Westenberg; J. Jolles

doi:10.1111/j.1600-0447.1984.tb02493.x

Zimeldine treatment of obsessive‐compulsive disorder: Biological and neuropsychological aspects

R. S. Kahn
, H. G.M. Westenberg
, J. Jolles

Research output: Contribution to journal › Article › peer-review

57 Scopus citations

Abstract

ABSTRACT– Six patients with Obsessive‐Compulsive Disorder (DSM III) were treated in an open uncontrolled trial with Zimeldine, for 8 weeks. All six patients had cognitive deficits before treatment. Five patients improved on the clinical symptoms. Four of these showed pronounced amelioration of their cognitive deficits.

Original language	English
Pages (from-to)	259-261
Number of pages	3
Journal	Acta Psychiatrica Scandinavica
Volume	69
Issue number	3
DOIs	https://doi.org/10.1111/j.1600-0447.1984.tb02493.x
State	Published - Mar 1984
Externally published	Yes

Keywords

Obsessive‐compulsive disorder
Zimeldine
antidepressant
neuropsychology
serotonin

Access to Document

10.1111/j.1600-0447.1984.tb02493.x

Cite this

@article{7cb173888c5a4b1983c2304cf30713d9,

title = "Zimeldine treatment of obsessive‐compulsive disorder: Biological and neuropsychological aspects",

abstract = "ABSTRACT{\textendash} Six patients with Obsessive‐Compulsive Disorder (DSM III) were treated in an open uncontrolled trial with Zimeldine, for 8 weeks. All six patients had cognitive deficits before treatment. Five patients improved on the clinical symptoms. Four of these showed pronounced amelioration of their cognitive deficits.",

keywords = "Obsessive‐compulsive disorder, Zimeldine, antidepressant, neuropsychology, serotonin",

author = "Kahn, \{R. S.\} and Westenberg, \{H. G.M.\} and J. Jolles",

year = "1984",

month = mar,

doi = "10.1111/j.1600-0447.1984.tb02493.x",

language = "English",

volume = "69",

pages = "259--261",

journal = "Acta Psychiatrica Scandinavica",

issn = "0001-690X",

publisher = "John Wiley and Sons Inc.",

number = "3",

}

TY - JOUR

T1 - Zimeldine treatment of obsessive‐compulsive disorder

T2 - Biological and neuropsychological aspects

AU - Kahn, R. S.

AU - Westenberg, H. G.M.

AU - Jolles, J.

PY - 1984/3

Y1 - 1984/3

N2 - ABSTRACT– Six patients with Obsessive‐Compulsive Disorder (DSM III) were treated in an open uncontrolled trial with Zimeldine, for 8 weeks. All six patients had cognitive deficits before treatment. Five patients improved on the clinical symptoms. Four of these showed pronounced amelioration of their cognitive deficits.

AB - ABSTRACT– Six patients with Obsessive‐Compulsive Disorder (DSM III) were treated in an open uncontrolled trial with Zimeldine, for 8 weeks. All six patients had cognitive deficits before treatment. Five patients improved on the clinical symptoms. Four of these showed pronounced amelioration of their cognitive deficits.

KW - Obsessive‐compulsive disorder

KW - Zimeldine

KW - antidepressant

KW - neuropsychology

KW - serotonin

UR - https://www.scopus.com/pages/publications/0021363612

U2 - 10.1111/j.1600-0447.1984.tb02493.x

DO - 10.1111/j.1600-0447.1984.tb02493.x

M3 - Article

C2 - 6231806

AN - SCOPUS:0021363612

SN - 0001-690X

VL - 69

SP - 259

EP - 261

JO - Acta Psychiatrica Scandinavica

JF - Acta Psychiatrica Scandinavica

IS - 3

ER -

Zimeldine treatment of obsessive‐compulsive disorder: Biological and neuropsychological aspects

Abstract

Keywords

Access to Document

Fingerprint

Cite this